These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 1966354

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The aggregation of human platelet induced by ganodermic acid S.
    Wang CN, Chen JC, Shiao MS, Wang CT.
    Biochim Biophys Acta; 1989 Nov 17; 986(1):151-60. PubMed ID: 2819092
    [Abstract] [Full Text] [Related]

  • 3. The inhibition of human platelet function by ganodermic acids.
    Wang CN, Chen JC, Shiao MS, Wang CT.
    Biochem J; 1991 Jul 01; 277 ( Pt 1)(Pt 1):189-97. PubMed ID: 1649599
    [Abstract] [Full Text] [Related]

  • 4. Platelet activity and phosphoinositide turnover increase with advancing age.
    Bastyr EJ, Kadrofske MM, Vinik AI.
    Am J Med; 1990 Jun 01; 88(6):601-6. PubMed ID: 2161185
    [Abstract] [Full Text] [Related]

  • 5. Elevation of cyclic AMP decreases phosphoinositide turnover and inhibits thrombin-induced secretion in human platelets.
    Ryningen A, Olav Jensen B, Holmsen H.
    Biochim Biophys Acta; 1998 Nov 02; 1394(2-3):235-48. PubMed ID: 9795233
    [Abstract] [Full Text] [Related]

  • 6. The inhibition of platelet-activating factor-induced platelet activation by oleic acid is associated with a decrease in polyphosphoinositide metabolism.
    Nunez D, Randon J, Gandhi C, Siafaka-Kapadai A, Olson MS, Hanahan DJ.
    J Biol Chem; 1990 Oct 25; 265(30):18330-8. PubMed ID: 2170407
    [Abstract] [Full Text] [Related]

  • 7. Decreased platelet phosphoinositide turnover and enhanced platelet activation in IDDM.
    Bastyr EJ, Kadrofske MM, Dershimer RC, Vinik AI.
    Diabetes; 1989 Sep 25; 38(9):1097-102. PubMed ID: 2548908
    [Abstract] [Full Text] [Related]

  • 8. Thrombin-induced abnormal platelet activation in spontaneously hypertensive rats is linked with phosphoinositides turnover and phosphorylation of 47,000 and 20,000 dalton proteins.
    Huzoor-Akbar, Anwer K.
    Thromb Res; 1988 Jan 01; 49(1):5-21. PubMed ID: 2831638
    [Abstract] [Full Text] [Related]

  • 9. U73122 affects the equilibria between the phosphoinositides as well as phospholipase C activity in unstimulated and thrombin-stimulated human and rabbit platelets.
    Vickers JD.
    J Pharmacol Exp Ther; 1993 Sep 01; 266(3):1156-63. PubMed ID: 8396627
    [Abstract] [Full Text] [Related]

  • 10. Synergism between thrombin and adrenaline (epinephrine) in human platelets. Marked potentiation of inositol phospholipid metabolism.
    Steen VM, Tysnes OB, Holmsen H.
    Biochem J; 1988 Jul 15; 253(2):581-6. PubMed ID: 2845924
    [Abstract] [Full Text] [Related]

  • 11. Reversible shape change in platelets is regulated by phosphatidylinositol metabolism.
    Dimitrov DP, Bühler FR.
    Biochem Biophys Res Commun; 1986 Dec 15; 141(2):673-81. PubMed ID: 3026389
    [Abstract] [Full Text] [Related]

  • 12. ADP-induced changes in [32P]phosphate labeling of phosphatidylinositol-4,5-bisphosphate in washed rabbit platelets made refractory by prior ADP stimulation.
    Leung NL, Vickers JD, Kinlough-Rathbone RL, Reimers HJ, Mustard JF.
    Biochem Biophys Res Commun; 1983 Jun 15; 113(2):483-90. PubMed ID: 6307289
    [Abstract] [Full Text] [Related]

  • 13. Effect of chlorpromazine on inositol-lipid signalling system in human thrombocytes.
    Strunecká A, Rípová D, Folk P.
    Physiol Bohemoslov; 1987 Jun 15; 36(6):495-501. PubMed ID: 2830631
    [Abstract] [Full Text] [Related]

  • 14. Evidence for tight metabolic control of the receptor-activated polyphosphoinositide cycle in human platelets.
    Steen VM, Tysnes OB, Holmsen H.
    Biochem J; 1989 Oct 15; 263(2):621-4. PubMed ID: 2557003
    [Abstract] [Full Text] [Related]

  • 15. The decrease in phosphatidylinositol 4,5-bisphosphate in ADP-stimulated washed rabbit platelets is not primarily due to phospholipase C activation.
    Vickers JD, Kinlough-Rathbone RL, Mustard JF.
    Biochem J; 1986 Jul 15; 237(2):327-32. PubMed ID: 3026316
    [Abstract] [Full Text] [Related]

  • 16. Altered platelet phosphatidylinositol metabolism in essential hypertension.
    Dimitrov D, Resink TJ, Müller FB, Bühler FR.
    J Hypertens Suppl; 1986 Dec 15; 4(6):S346-8. PubMed ID: 3039092
    [Abstract] [Full Text] [Related]

  • 17. 1-Oleoyl-2-acetyl-glycerol (OAG) stimulates the formation of phosphatidylinositol 4-phosphate in intact human platelets.
    de Chaffoy de Courcelles D, Roevens P, Van Belle H.
    Biochem Biophys Res Commun; 1984 Sep 17; 123(2):589-95. PubMed ID: 6091634
    [Abstract] [Full Text] [Related]

  • 18. Platelet activating factor (PAF-acether) promotes an early degradation of phosphatidylinositol-4,5-biphosphate in rabbit platelets.
    Mauco G, Chap H, Douste-Blazy L.
    FEBS Lett; 1983 Mar 21; 153(2):361-5. PubMed ID: 6311620
    [Abstract] [Full Text] [Related]

  • 19. Collagen-induced binding to human platelets of platelet-derived growth factor leading to inhibition of P43 and P20 phosphorylation.
    Bryckaert MC, Rendu F, Tobelem G, Wasteson A.
    J Biol Chem; 1989 Mar 15; 264(8):4336-41. PubMed ID: 2538439
    [Abstract] [Full Text] [Related]

  • 20. The stimulatory effects of cationic amphiphilic drugs on human platelets treated with thrombin.
    Tharmapathy P, Fukami MH, Holmsen H.
    Biochem Pharmacol; 2000 Nov 01; 60(9):1267-77. PubMed ID: 11008120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.